var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('5/8 - 9:11 AM \; \; | \n'); } if (allow) { document.write('Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study | \n'); } if (allow) { document.write('
5/6 - 9:06 AM \; \; | \n'); } if (allow) { document.write('Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs | \n'); } if (allow) { document.write('
5/1 - 6:07 AM \; \; | \n'); } if (allow) { document.write('Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance | \n'); } if (allow) { document.write('
4/30 - 3:41 PM \; \; | \n'); } if (allow) { document.write('Lexaria to Receive $4.7 Million Gross Proceeds in Warrant Exercise and Issuance | \n'); } if (allow) { document.write('
4/16 - 9:16 AM \; \; | \n'); } if (allow) { document.write('Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study | \n'); } if (allow) { document.write('
4/2 - 9:01 AM \; \; | \n'); } if (allow) { document.write('Lexaria Awarded New Patents | \n'); } if (allow) { document.write('
3/21 - 9:22 AM \; \; | \n'); } if (allow) { document.write('Lexaria to Present at The LD Micro Invitational XIV | \n'); } if (allow) { document.write('
3/14 - 9:21 AM \; \; | \n'); } if (allow) { document.write('Lexaria Appoints Nelson Cabatuan as Chief Financial Officer | \n'); } if (allow) { document.write('
3/7 - 9:08 AM \; \; | \n'); } if (allow) { document.write('Lexaria Awards Contract For Next GLP-1 Human Pilot Study | \n'); } if (allow) { document.write('
3/5 - 9:06 AM \; \; | \n'); } if (allow) { document.write('Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1 | \n'); } if (allow) { document.write('
3/4 - 9:16 AM \; \; | \n'); } if (allow) { document.write('7% Weight Loss in Animals Supports Lexaria s Next 8-week Animal Study | \n'); } if (allow) { document.write('
3/1 - 8:21 AM \; \; | \n'); } if (allow) { document.write('Lexaria Announces FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial | \n'); } if (allow) { document.write('
2/16 - 4:06 PM \; \; | \n'); } if (allow) { document.write('Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | \n'); } if (allow) { document.write('
2/15 - 8:01 AM \; \; | \n'); } if (allow) { document.write('Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | \n'); } if (allow) { document.write('
2/1 - 6:07 AM \; \; | \n'); } if (allow) { document.write('Lexaria\'s Submits Investigational New Drug Application | \n'); } if (allow) { document.write('
1/30 - 8:51 AM \; \; | \n'); } if (allow) { document.write('Lexaria\'s Submits Investigational New Drug Application | \n'); } if (allow) { document.write('
1/30 - 8:47 AM \; \; | \n'); } if (allow) { document.write('Lexaria\'s Submits Investigational New Drug Application | \n'); } if (allow) { document.write('
1/24 - 8:51 AM \; \; | \n'); } if (allow) { document.write('Lexaria Releases Annual Letter from the CEO | \n'); } if (allow) { document.write('
1/24 - 8:47 AM \; \; | \n'); } if (allow) { document.write('Lexaria Releases Annual Letter from the CEO | \n'); } if (allow) { document.write('
1/16 - 9:16 AM \; \; | \n'); } if (allow) { document.write('Lexaria Unveils Extensive Planned 2024 GLP-1 Study Program | \n'); } if (allow) { document.write('
more news | \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' |